Variant report

Variant	nsv1007567
Chromosome Location	chr4:69327051-69540013
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1199)
CpG islands
(count:793)
Chromatin interactive
region (count:12)
LncRNA
region (count:6)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1199 , 50 per page) page: 1 2 3 4 5 6 7 ... 24

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:69479543-69479775	HepG2	liver:	n/a	n/a
2	ARID3A	chr4:69464978-69465269	HepG2	liver:	n/a	n/a
3	ARID3A	chr4:69386831-69387059	HepG2	liver:	n/a	n/a
4	ARID3A	chr4:69489457-69489609	HepG2	liver:	n/a	n/a
5	ARID3A	chr4:69521827-69522720	HepG2	liver:	n/a	n/a
6	ARID3A	chr4:69524230-69524826	HepG2	liver:	n/a	n/a
7	ARID3A	chr4:69364158-69364549	HepG2	liver:	n/a	n/a
8	BATF	chr4:69441350-69441539	GM12878	blood:	n/a	n/a
9	BATF	chr4:69523003-69523215	GM12878	blood:	n/a	n/a
10	BATF	chr4:69419767-69419937	GM12878	blood:	n/a	n/a
11	BATF	chr4:69522977-69523278	GM12878	blood:	n/a	n/a
12	BATF	chr4:69441348-69441590	GM12878	blood:	n/a	n/a
13	BATF	chr4:69538989-69539205	GM12878	blood:	n/a	n/a
14	BATF	chr4:69364212-69364472	GM12878	blood:	n/a	n/a
15	BCL11A	chr4:69419791-69419969	GM12878	blood:	n/a	n/a
16	BCL11A	chr4:69523069-69523272	GM12878	blood:	n/a	n/a
17	BCL3	chr4:69536262-69536632	A549	lung:	n/a	n/a
18	BHLHE40	chr4:69522248-69522562	GM12878	blood:	n/a	n/a
19	BHLHE40	chr4:69435323-69435604	K562	blood:	n/a	n/a
20	BHLHE40	chr4:69364150-69364589	GM12878	blood:	n/a	n/a
21	CCNT2	chr4:69328625-69328750	K562	blood:	n/a	n/a
22	CEBPB	chr4:69536174-69536504	A549	lung:	n/a	chr4:69536341-69536354
23	CEBPB	chr4:69463247-69463520	HepG2	liver:	n/a	n/a
24	CEBPB	chr4:69327525-69327817	MCF-7	breast:	n/a	n/a
25	CEBPB	chr4:69530297-69530431	A549	lung:	n/a	chr4:69530340-69530351
26	CEBPB	chr4:69471903-69472154	HepG2	liver:	n/a	n/a
27	CEBPB	chr4:69419232-69419353	HepG2	liver:	n/a	n/a
28	CEBPB	chr4:69431039-69431053	HepG2	liver:	n/a	chr4:69431039-69431050 chr4:69431041-69431050
29	CEBPB	chr4:69447506-69447748	A549	lung:	n/a	n/a
30	CEBPB	chr4:69482880-69482916	A549	lung:	n/a	n/a
31	CEBPB	chr4:69447453-69447718	K562	blood:	n/a	n/a
32	CEBPB	chr4:69447436-69447754	Hela-S3	cervix:	n/a	n/a
33	CEBPB	chr4:69530299-69530470	HepG2	liver:	n/a	chr4:69530340-69530351
34	CEBPB	chr4:69536204-69536567	A549	lung:	n/a	chr4:69536341-69536354
35	CEBPB	chr4:69462434-69462560	A549	lung:	n/a	chr4:69462483-69462500
36	CEBPB	chr4:69536198-69536502	MCF-7	breast:	n/a	chr4:69536341-69536354
37	CEBPB	chr4:69536277-69536474	HepG2	liver:	n/a	chr4:69536341-69536354
38	CTCF	chr4:69434841-69435064	MCF-7	breast:	n/a	n/a
39	CTCF	chr4:69364216-69364448	A549	lung:	n/a	chr4:69364312-69364333 chr4:69364310-69364328 chr4:69364311-69364327
40	CTCF	chr4:69364220-69364370	NHDF-neo	bronchial:	n/a	chr4:69364312-69364333 chr4:69364310-69364328 chr4:69364311-69364327
41	CTCF	chr4:69443406-69443650	A549	lung:	n/a	n/a
42	CTCF	chr4:69537058-69537260	GM19239	blood:	n/a	n/a
43	CTCF	chr4:69523077-69523274	GM10266	blood:	n/a	n/a
44	CTCF	chr4:69434914-69435005	Pancreas_OC	pancreas:	n/a	n/a
45	CTCF	chr4:69364260-69364410	HBMEC	blood vessel:	n/a	chr4:69364312-69364333 chr4:69364310-69364328 chr4:69364311-69364327
46	CTCF	chr4:69538954-69539224	K562	blood:	n/a	n/a
47	CTCF	chr4:69363958-69364589	SK-N-SH	brain:	n/a	chr4:69364312-69364333 chr4:69364310-69364328 chr4:69364311-69364327
48	CTCF	chr4:69419791-69419934	GM12892	blood:	n/a	n/a
49	CTCF	chr4:69523075-69523264	GM13976	blood:	n/a	n/a
50	CTCF	chr4:69364108-69364552	GM12878	blood:	n/a	chr4:69364312-69364333 chr4:69364310-69364328 chr4:69364311-69364327

(count:793 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:69522639-69522689	PrEC	prostate:	n/a
2	chr4:69435250-69435300	Jurkat	blood:	n/a
3	chr4:69537806-69537856	HEK293	kidney:	embryo
4	chr4:69435601-69435651	HMEC	breast:	n/a
5	chr4:69537826-69537876	PANC-1	pancreas:	n/a
6	chr4:69514031-69514081	GM19239	blood:	n/a
7	chr4:69435250-69435300	T-47D	breast:	n/a
8	chr4:69355121-69355171	NT2-D1	testis:	n/a
9	chr4:69435601-69435651	HEK293	kidney:	embryo
10	chr4:69514031-69514081	NT2-D1	testis:	n/a
11	chr4:69514031-69514081	HIPEpiC	eye:	n/a
12	chr4:69514031-69514081	HMEC	breast:	n/a
13	chr4:69522639-69522689	MCF-7	breast:	n/a
14	chr4:69381368-69381418	ECC-1	luminal epithelium:	n/a
15	chr4:69381368-69381418	T-47D	breast:	n/a
16	chr4:69355121-69355171	HMEC	breast:	n/a
17	chr4:69434475-69434525	PFSK-1	brain:	n/a
18	chr4:69514031-69514081	PANC-1	pancreas:	n/a
19	chr4:69537589-69537639	HRE	kidney:	n/a
20	chr4:69381368-69381418	PANC-1	pancreas:	n/a
21	chr4:69537826-69537876	HIPEpiC	eye:	n/a
22	chr4:69381368-69381418	NH-A	brain:	n/a
23	chr4:69537589-69537639	SK-N-MC	brain:	n/a
24	chr4:69522639-69522689	GM12892	blood:	n/a
25	chr4:69537826-69537876	HUVEC	blood vessel:	n/a
26	chr4:69536319-69536369	Caco-2	colon:	n/a
27	chr4:69381368-69381418	GM19239	blood:	n/a
28	chr4:69434475-69434525	HEK293	kidney:	embryo
29	chr4:69435601-69435651	AG09319	gingival:	n/a
30	chr4:69537589-69537639	AG04449	skin:	fetal
31	chr4:69537589-69537639	BE2_C	brain:	n/a
32	chr4:69514031-69514081	GM12892	blood:	n/a
33	chr4:69434475-69434525	SK-N-MC	brain:	n/a
34	chr4:69537589-69537639	LNCaP	prostate:	n/a
35	chr4:69435250-69435300	HIPEpiC	eye:	n/a
36	chr4:69435593-69435643	Jurkat	blood:	n/a
37	chr4:69537806-69537856	GM06990	blood:	n/a
38	chr4:69355121-69355171	Hela-S3	cervix:	n/a
39	chr4:69340916-69340966	AG09319	gingival:	n/a
40	chr4:69435601-69435651	HPAEpiC	pulmonary alveolar:	n/a
41	chr4:69435601-69435651	SKMC	muscle:	n/a
42	chr4:69537826-69537876	AG04449	skin:	fetal
43	chr4:69536319-69536369	BJ	skin:	n/a
44	chr4:69435250-69435300	Hepatocyte	liver:	n/a
45	chr4:69435601-69435651	AoSMC	blood vessel:	n/a
46	chr4:69340916-69340966	T-47D	breast:	n/a
47	chr4:69522639-69522689	RPTEC	kidney:	n/a
48	chr4:69514031-69514081	AG04449	skin:	fetal
49	chr4:69536319-69536369	HIPEpiC	eye:	n/a
50	chr4:69537826-69537876	Caco-2	colon:	n/a

(count:12 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:69211043..69213753-chr4:69341284..69343236,2	K562	blood:
2	chr4:69330018..69331837-chr4:69335427..69337976,2	MCF-7	breast:
3	chr4:69375140..69375898-chr4:69492301..69492816,2	MCF-7	breast:
4	chr4:69215797..69217317-chr4:69361139..69363891,2	MCF-7	breast:
5	chr4:69330018..69331837-chr4:69335427..69337976,2	MCF-7	breast:
6	chr4:69326187..69328959-chr4:69331153..69333884,3	MCF-7	breast:
7	chr4:69313083..69315969-chr4:69334821..69336429,2	MCF-7	breast:
8	chr4:69363348..69364328-chr4:69890914..69891634,2	MCF-7	breast:
9	chr4:69362843..69365661-chr4:69770776..69774163,4	MCF-7	breast:
10	chr4:68794694..68797024-chr4:69366841..69368465,2	MCF-7	breast:
11	chr4:69235222..69236888-chr4:69330787..69333108,2	MCF-7	breast:
12	chr4:69375140..69375898-chr4:69492301..69492816,2	MCF-7	breast:

(count:6 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-UGT2B15-2	chr4:69493903-69494617	NONHSAT096737
2	lnc-UGT2B17-1	chr4:69375159-69375392	NONHSAT096733
3	lnc-UGT2B17-1	chr4:69382627-69383365	NONHSAT096733
4	lnc-UGT2B15-2	chr4:69492565-69492700	NONHSAT096737
5	lnc-TMPRSS11E-2	chr4:69480137-69480731	NONHSAT096735
6	lnc-UGT2B15-3	chr4:69481111-69481855	NONHSAT096736

No data

Variant related genes	Relation type
ENSG00000249472	TF binding region
ENSG00000251074	TF binding region
TMPRSS11E	TF binding region
ENSG00000251101	TF binding region
UGT2B17	TF binding region
UGT2B15	TF binding region
UGT2B29P	TF binding region
ENSG00000249472	CpG island
ENSG00000251074	CpG island
TMPRSS11E	CpG island
ENSG00000251101	CpG island
UGT2B17	CpG island
UGT2B15	CpG island
UGT2B29P	CpG island
ENSG00000087128	chromatin interactions
ENSG00000083896	chromatin interactions
ENSG00000272626	chromatin interactions
ENSG00000249985	chromatin interactions

Extended variants
information (count: 6281 )
Associated
traits (count: 92 )

Variant overlapped rSNPs/rCNVs (count:6281 , 50 per page) page: 1 2 3 4 5 6 7 ... 126

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs145386370	chr4:69327121-69327122	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs573563304	chr4:69327133-69327134	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs542497782	chr4:69327152-69327153	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs562470412	chr4:69327160-69327161	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs575625796	chr4:69327200-69327201	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs543104758	chr4:69327206-69327207	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs545026031	chr4:69327240-69327241	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs561832503	chr4:69327267-69327268	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs527381209	chr4:69327337-69327338	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs540444920	chr4:69327344-69327345	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs148771829	chr4:69327429-69327430	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs375197528	chr4:69327498-69327499	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs201776514	chr4:69327502-69327503	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs369628386	chr4:69327503-69327504	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs549678807	chr4:69327517-69327518	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs201032244	chr4:69327588-69327589	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs373099493	chr4:69327625-69327626	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs151337153	chr4:69327634-69327635	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs373303099	chr4:69327649-69327650	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs377019664	chr4:69327700-69327701	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs551762391	chr4:69327718-69327719	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs144869660	chr4:69327738-69327739	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs147927119	chr4:69327749-69327750	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs142098345	chr4:69327752-69327753	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs567099951	chr4:69327760-69327761	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs536085626	chr4:69327798-69327799	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs185424730	chr4:69327827-69327828	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs189598477	chr4:69327850-69327851	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs145845749	chr4:69327910-69327911	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs558544689	chr4:69327923-69327924	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs36028307	chr4:69327932-69327933	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs541112732	chr4:69327956-69327957	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs181608074	chr4:69327960-69327961	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs186845940	chr4:69327990-69327991	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs543287819	chr4:69328032-69328033	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs569858217	chr4:69328033-69328034	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs532037290	chr4:69328037-69328038	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs192145677	chr4:69328097-69328098	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs571598677	chr4:69328124-69328125	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs34825904	chr4:69328132-69328133	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs36044297	chr4:69328133-69328134	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs71671427	chr4:69328190-69328191	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs527711501	chr4:69328249-69328250	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs183314204	chr4:69328288-69328289	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs186524347	chr4:69328294-69328295	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs536001521	chr4:69328295-69328296	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs373103893	chr4:69328306-69328307	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs11405512	chr4:69328307-69328308	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs150378447	chr4:69328387-69328388	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs569821599	chr4:69328397-69328398	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:92)

Disease	PMID	Source
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Lung cancer	18438408	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	21922591	CNVD
Parkinson disease	21956041	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Parkinson disease	18923514	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Breast cancer	16272173	CNVD
Multiple myeloma	16616336	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Colorectal cancer	16272173	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Acute myeloid leukemia	21251322	CNVD
Prostate cancer	16573809	CNVD
Osteoporosis	18992858	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Myelodysplastic syndrome	21251322	CNVD
Multiple myeloma	17550852	CNVD
Graft versus host disease	20877625	CNVD
Breast cancer	21990379	CNVD
Myelofibrosis	22110671	CNVD
Osteoporosis	20877625	CNVD
Osteoporosis	19737800	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Glioblastoma multiforme	21138945	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Oral cancer	21386901	CNVD
Alcoholism	21790672	CNVD
small cell lung cancer	20016488	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Schizophrenia	20967226	CNVD
early-passage human iPS cells	21368824	CNVD
Breast cancer	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Non-syndromic sensorineural hearing loss	22297974	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:374 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:69319600-69335800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
2	chr4:69326200-69329600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
3	chr4:69326200-69329800	Weak transcription	HUES6 Cell Line	embryonic stem cell
4	chr4:69326200-69334200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
5	chr4:69326200-69348800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
6	chr4:69326600-69331000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
7	chr4:69326600-69334200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
8	chr4:69327400-69327800	Enhancers	NHEK	skin
9	chr4:69327400-69328800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
10	chr4:69327400-69332800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
11	chr4:69327400-69333200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
12	chr4:69327600-69328400	Weak transcription	Muscle Satellite Cultured Cells	--
13	chr4:69327600-69333600	Enhancers	HMEC	breast
14	chr4:69327800-69329600	Weak transcription	NHEK	skin
15	chr4:69328400-69329600	Enhancers	Muscle Satellite Cultured Cells	--
16	chr4:69328400-69332600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
17	chr4:69328800-69329800	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
18	chr4:69329200-69330000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
19	chr4:69329400-69332800	Enhancers	NHDF-Ad	bronchial
20	chr4:69329600-69329800	Enhancers	iPS-15b Cell Line	embryonic stem cell
21	chr4:69329600-69329800	Enhancers	HSMMtube	muscle
22	chr4:69329600-69330000	Flanking Active TSS	Muscle Satellite Cultured Cells	--
23	chr4:69329600-69330000	Enhancers	Colon Smooth Muscle	Colon
24	chr4:69329600-69330200	Enhancers	A549	lung
25	chr4:69329600-69332800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
26	chr4:69329600-69332800	Enhancers	HSMM	muscle
27	chr4:69329600-69332800	Enhancers	NH-A	brain
28	chr4:69329600-69333000	Enhancers	NHEK	skin
29	chr4:69329800-69330200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
30	chr4:69329800-69330600	Enhancers	HUES6 Cell Line	embryonic stem cell
31	chr4:69329800-69331200	Weak transcription	HSMMtube	muscle
32	chr4:69329800-69332800	Enhancers	Osteobl	bone
33	chr4:69329800-69333200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
34	chr4:69330000-69331200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
35	chr4:69330000-69331800	Enhancers	Muscle Satellite Cultured Cells	--
36	chr4:69330000-69332800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
37	chr4:69330200-69330600	Enhancers	iPS-15b Cell Line	embryonic stem cell
38	chr4:69330200-69332000	Weak transcription	A549	lung
39	chr4:69330400-69331400	Enhancers	iPS-18 Cell Line	embryonic stem cell
40	chr4:69330800-69331800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
41	chr4:69331000-69331600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
42	chr4:69331000-69332000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
43	chr4:69331000-69333200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
44	chr4:69331200-69331800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
45	chr4:69331200-69332400	Enhancers	HSMMtube	muscle
46	chr4:69331400-69333000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
47	chr4:69331600-69332200	Enhancers	NHLF	lung
48	chr4:69331800-69332000	Flanking Active TSS	Muscle Satellite Cultured Cells	--
49	chr4:69332000-69332200	Enhancers	Muscle Satellite Cultured Cells	--
50	chr4:69332000-69332400	Enhancers	A549	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links